These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 1727475)

  • 21. Binding of soluble CD4 proteins to human immunodeficiency virus type 1 and infected cells induces release of envelope glycoprotein gp120.
    Hart TK; Kirsh R; Ellens H; Sweet RW; Lambert DM; Petteway SR; Leary J; Bugelski PJ
    Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2189-93. PubMed ID: 2006155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Soluble CD4 enhances the efficacy of immunotoxins directed against gp41 of the human immunodeficiency virus.
    Pincus SH; McClure J
    Proc Natl Acad Sci U S A; 1993 Jan; 90(1):332-6. PubMed ID: 8419938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding.
    Wyatt R; Moore J; Accola M; Desjardin E; Robinson J; Sodroski J
    J Virol; 1995 Sep; 69(9):5723-33. PubMed ID: 7543586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell fusion mediated by interaction of a hybrid CD4.CD8 molecule with the human immunodeficiency virus type 1 envelope glycoprotein does occur after a long lag time.
    Golding H; Blumenthal R; Manischewitz J; Littman DR; Dimitrov DS
    J Virol; 1993 Nov; 67(11):6469-75. PubMed ID: 8411350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of the I559P gp41 change on the conformation and function of the human immunodeficiency virus (HIV-1) membrane envelope glycoprotein trimer.
    Alsahafi N; Debbeche O; Sodroski J; Finzi A
    PLoS One; 2015; 10(4):e0122111. PubMed ID: 25849367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of soluble CD4 on simian immunodeficiency virus infection of CD4-positive and CD4-negative cells.
    Schenten D; Marcon L; Karlsson GB; Parolin C; Kodama T; Gerard N; Sodroski J
    J Virol; 1999 Jul; 73(7):5373-80. PubMed ID: 10364284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human immunodeficiency virus type 2 envelope glycoprotein: differential CD4 interactions of soluble gp120 versus the assembled envelope complex.
    Mulligan MJ; Ritter GD; Chaikin MA; Yamshchikov GV; Kumar P; Hahn BH; Sweet RW; Compans RW
    Virology; 1992 Mar; 187(1):233-41. PubMed ID: 1736526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topological layers in the HIV-1 gp120 inner domain regulate gp41 interaction and CD4-triggered conformational transitions.
    Finzi A; Xiang SH; Pacheco B; Wang L; Haight J; Kassa A; Danek B; Pancera M; Kwong PD; Sodroski J
    Mol Cell; 2010 Mar; 37(5):656-67. PubMed ID: 20227370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), Is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus.
    Chertova E; Bess JW; Crise BJ; Sowder II RC; Schaden TM; Hilburn JM; Hoxie JA; Benveniste RE; Lifson JD; Henderson LE; Arthur LO
    J Virol; 2002 Jun; 76(11):5315-25. PubMed ID: 11991960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetics of HIV-1 interactions with sCD4 and CD4+ cells: implications for inhibition of virus infection and initial steps of virus entry into cells.
    Dimitrov DS; Willey RL; Martin MA; Blumenthal R
    Virology; 1992 Apr; 187(2):398-406. PubMed ID: 1347667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lineage-Specific Differences between the gp120 Inner Domain Layer 3 of Human Immunodeficiency Virus and That of Simian Immunodeficiency Virus.
    Ding S; Medjahed H; Prévost J; Coutu M; Xiang SH; Finzi A
    J Virol; 2016 Nov; 90(22):10065-10073. PubMed ID: 27535053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conformational changes in cell surface HIV-1 envelope glycoproteins are triggered by cooperation between cell surface CD4 and co-receptors.
    Jones PL; Korte T; Blumenthal R
    J Biol Chem; 1998 Jan; 273(1):404-9. PubMed ID: 9417096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conformational perturbation of the envelope glycoprotein gp120 of human immunodeficiency virus type 1 by soluble CD4 and the lectin succinyl Con A.
    Pal R; DeVico A; Rittenhouse S; Sarngadharan MG
    Virology; 1993 Jun; 194(2):833-7. PubMed ID: 8503188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two mechanisms of soluble CD4 (sCD4)-mediated inhibition of human immunodeficiency virus type 1 (HIV-1) infectivity and their relation to primary HIV-1 isolates with reduced sensitivity to sCD4.
    Orloff SL; Kennedy MS; Belperron AA; Maddon PJ; McDougal JS
    J Virol; 1993 Mar; 67(3):1461-71. PubMed ID: 8437224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simple methods for monitoring HIV-1 and HIV-2 gp120 binding to soluble CD4 by enzyme-linked immunosorbent assay: HIV-2 has a 25-fold lower affinity than HIV-1 for soluble CD4.
    Moore JP
    AIDS; 1990 Apr; 4(4):297-305. PubMed ID: 2190604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Naturally occurring soluble CD4 in patients with human immunodeficiency virus infection.
    Peakman M; Senaldi G; Foote N; McManus TJ; Vergani D
    J Infect Dis; 1992 May; 165(5):799-804. PubMed ID: 1349032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neutralization of human immunodeficiency virus type 1 by sCD4-17b, a single-chain chimeric protein, based on sequential interaction of gp120 with CD4 and coreceptor.
    Dey B; Del Castillo CS; Berger EA
    J Virol; 2003 Mar; 77(5):2859-65. PubMed ID: 12584309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Envelope conformational changes induced by human immunodeficiency virus type 1 attachment inhibitors prevent CD4 binding and downstream entry events.
    Ho HT; Fan L; Nowicka-Sans B; McAuliffe B; Li CB; Yamanaka G; Zhou N; Fang H; Dicker I; Dalterio R; Gong YF; Wang T; Yin Z; Ueda Y; Matiskella J; Kadow J; Clapham P; Robinson J; Colonno R; Lin PF
    J Virol; 2006 Apr; 80(8):4017-25. PubMed ID: 16571818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An inducible HIV type 1 gp41 HR-2 peptide-binding site on HIV type 1 envelope gp120.
    Alam SM; Paleos CA; Liao HX; Scearce R; Robinson J; Haynes BF
    AIDS Res Hum Retroviruses; 2004 Aug; 20(8):836-45. PubMed ID: 15320988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional and immunologic characterization of human immunodeficiency virus type 1 envelope glycoproteins containing deletions of the major variable regions.
    Wyatt R; Sullivan N; Thali M; Repke H; Ho D; Robinson J; Posner M; Sodroski J
    J Virol; 1993 Aug; 67(8):4557-65. PubMed ID: 8331723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.